CTRI/2021/01/030388进行中（未招募）2 期
An Open labeled Multicentric Pilot study to study the safety and efficacy of Silvernova skin cream (20 ppm) in ambulant patients with selected skin diseases
Viridis BioPharma Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Male and female aged 18 to 65 who are suffering from mild or moderate fungal infection like intertrigo, tinea, bullous skin disorders like pemphigus or pemphigoids and intense skin care and repair post cosmetic skin procedures including laser procedures, peels. Based on appearance of lesions, Investigators will have the judgement on fungal infection being mild, moderate, or severe.
- •2.Willing to give informed consent
排除标准
- •1.Patients who are suffering from any major systemic illnesses.
- •2.Patients Participation in any other clinical trials evaluating investigational pharmaceuticals orbiologics within 3 months or devices within 30 days of admission to the study.
- •3.Cases with secondary infections will be excluded from this study.
- •4.Severe cases of fungal infection.
研究者
相似试验
进行中（未招募）
不适用
A Multicenter, Open-Label, Pilot Study to Explore the Safety and Efficacy of Intravenous Bortezomib in Patients with Hepatitis C - ViroLogik CT-02repeated dose treatment with Bortezomib in patients with chronic HCV infectionMedDRA version: 9.1Level: LLTClassification code 10002724Term: Anti-HCV positiveEUCTR2008-000495-24-DEViroLogik GmbH10
进行中（未招募）
不适用
A multicenter open label randomized pilot study, to compare retinal nerve fiber layer thickness measured by Optical Coherence Tomography after treatment with daily 20 mg glatiramer acetate subcutaneously or after no treatment, in patients with a clinical isolated syndrome, other than optic neuritis or early relapsing remitting multiple sclerosis patients - OCTclinical isolated syndromeMedDRA version: 9.1Level: LLTClassification code 10028248Term: Multiple sclerosis-like syndromeEUCTR2009-013129-41-NLAmphia Ziekenhuis
已完成
不适用
A pilot, open-label, multicentre study to investigate the safety of calf intestine alkaline phosphatase in patients with fulminant active ulcerative colitis refractory to steroid therapyFulminant ulcerative colitisDigestive SystemUlcerative colitis unspecifiedISRCTN64619216AM-Pharma B.V. (The Netherlands)20
已完成
4 期
A study to assess the safety and efficacy of TumsUP® oral drops in the treatment of baby colic.CTRI/2020/04/024552Zuventus Healthcare Limited200
已完成
4 期
A observational study to evaluate the efficacy and safety of Ranibizumab in patients with visual impairment due to Diabetic Macular Edema(DMECTRI/2015/06/005945ovartis Healthcare Pvt Ltd